The agenda for the 3 December 2014 Transparency Commission meeting is now available. The Commission will consider the following medicines:

• Everolimus (Votubia) - new medicine
• Everolimus (Votubia) - new indication
• Cholic acid (Kolbam) - new medicine
• Olodaterol hydrochloride (Striverdi Respimat) - new medicine
• Beclomethasone propionate with eformoterol fumarate dihydrate (Innovair/Formodual) - new indication
• Fluticasone furoate with vilanterol trifenatate (Relvar Ellipta) - new medicine
• Daclatasvir dihydrochloride (Daklinza)  - new medicine
• Zonisamide (Zonegran) - new indication

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-11/odj_ct_03122014_internet.pdf